Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QUADRISE PLC Regulatory Filings 2021

Aug 23, 2021

7865_rns_2021-08-23_9870e456-7352-4d3c-bc53-dfff47e49e66.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3835J

Quadrise Fuels International PLC

23 August 2021

23 August 2021

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

Greenfield Commercial Trial Agreement Extension

Quadrise, the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, which are low-cost, cleaner alternatives to heavy fuel oil and biofuels, announces that the Commercial Trial Agreement ("Agreement") with Greenfield Energy LLC ("Greenfield"), the joint venture between Valkor LLC and TomCo Energy plc detailed in the announcement dated 18 August 2020, has been extended to 31 December 2021. All other terms and conditions under the Commercial Trial Agreement remain the same.

For further information, please contact:

Quadrise Fuels International Plc
Mike Kirk, Chairman +44 (0)20 7031 7321
Jason Miles, Chief Executive Officer [email protected]
Nominated Adviser
Cenkos Securities plc
Ben Jeynes

Katy Birkin
+44 (0)20 7397 8900
Joint Brokers
Peel Hunt LLP
Richard Crichton +44 (0)20 7418 8900
David McKeown
Shore Capital Stockbrokers Limited
Toby Gibbs

Fiona Conroy
+44 (0)20 7408 4090
Public & Investor Relations
FTI Consulting
Ben Brewerton +44 (0)20 3727 1000
Ntobeko Chidavaenzi

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGRPPUWGRUPGGMU